Vestibular paroxysmia: Long-term clinical outcome after treatment.

ABSTRACT:

Objective

To study the long-term treatment outcome of vestibular paroxysmia (VP).

Study design

Retrospective study.

Setting

Tertiary referral hospital.

Methods

We analyzed records of 29 consecutive patients who were diagnosed with VP and who were treated with VP-specific anticonvulsants for at least 3 months. Patients were followed for a minimum of 6 months. We recorded and assessed starting and target dosage of medications, time to achieve adequate therapeutic response, adverse effects, and the rates of short-term and long-term remission without medication.

Results

All 29 patients were started on oxcarbazepine as first-line treatment, and 93.1% and 100% of patients reported good-to-excellent therapeutic response within 2 and 4 weeks, respectively. Three

SUBMITTER: Chen CC 

PROVIDER: S-EPMC9614226 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature